[HTML][HTML] Glioblastoma multiforme selective nanomedicines for improved anti-cancer treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - Pharmaceutics, 2022 - mdpi.com
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - search.proquest.com
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - europepmc.org
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

[HTML][HTML] Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - ncbi.nlm.nih.gov
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - iris.unimore.it
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - search.ebscohost.com
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

[PDF][PDF] Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 2022, 14, 1450

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - 2022 - researchgate.net
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

[PDF][PDF] Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - 2022 - researchrepository.ul.ie
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

[PDF][PDF] Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 2022, 14, 1450

JT Duskey, A Rinaldi, I Ottonelli, R Caraffi… - 2022 - iris.unimore.it
Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …